A phase II study of biweekly cisplatin, fixed dose rate gemcitabine and infusional 5-fluorouracil in patients with metastatic pancreatic and biliary cancers

OBJECTIVES: Combinations of gemcitabine, 5-fluorouracil (5-FU), and platinum have demonstrated improved outcomes compared with singlet chemotherapy in pancreatic and biliary cancers. This phase II study examined efficacy and safety of a novel schedule of cisplatin, fixed-dose-rate (FDR) gemcitabine...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Am J Clin Oncol
Huvudupphovsmän: Davis, Elizabeth J., Griffith, Kent A., Kim, Edward J., Ruch, Joshua M., McDonnell, Kevin J., Zalupski, Mark M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2018
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4854803/
https://ncbi.nlm.nih.gov/pubmed/26535993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000240
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk